Synageva BioPharma (GEVA)

Add to Watchlists
Create an Alert
78.90 -0.48  -0.60% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
GEVA Price Chart
View All Events

GEVA Events

Date Type Description
Mar 03 Misc Synageva BioPharma Corp Q4 2013 Earnings Conference Call
Mar 03 Earnings Synageva BioPharma Corp Q4 2013 Earnings Results. Estimate: -1.02.
Oct 29 Earnings Synageva BioPharma™ Reports Third Quarter 2013 Financial Results. Estimate: -0.93.
Aug 05 Earnings Synageva BioPharma™ Reports Second Quarter 2013 Financial Results and Announces Appointment of Chief Operating Officer. Estimate: -0.74.
May 07 Earnings Synageva BioPharma™ Reports First Quarter 2013 Financial Results. Estimate: -0.68.
View All Performance Charts

GEVA Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Synageva BioPharma is up 51.94% over the last year vs S&P 500 Total Return up 23.54%, Alexion Pharmaceuticals up 58.10%, and Actelion up 72.03%.

Get Quote for

PDF Report for GEVA

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download GEVA Pro Report PDF
Advertisement

Portfolio Strategies Featuring GEVA

Did Synageva BioPharma make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

GEVA Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Synageva BioPharma Corp is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.

Recent Quotes

Symbol Price Chg Chg % Market Cap
GEVA 78.90 -0.48 -0.60% 2.440B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.